U.S. markets open in 3 hours 20 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
126.72+1.67 (+1.34%)
At close: 4:02PM EDT
126.62 -0.10 (-0.08%)
Pre-Market: 05:49AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close125.05
Bid0.00 x 800
Ask0.00 x 1200
Day's Range124.88 - 126.84
52 Week Range103.13 - 129.70
Avg. Volume4,664,842
Market Cap224.652B
Beta (5Y Monthly)0.67
PE Ratio (TTM)31.44
EPS (TTM)4.03
Earnings DateOct 20, 2021
Forward Dividend & Yield1.80 (1.42%)
Ex-Dividend DateOct 14, 2021
1y Target Est137.05
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-13% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ABT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Abbott Laboratories
    Analyst Report: Abbott LaboratoriesAbbott Laboratories is a diversified healthcare company that develops, manufactures and markets a wide range of medical products and services. Its main product lines are nutritionals for adults and infants, diagnostic systems, vascular implants, cardiac rhythm management products, and diabetes care products.
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • Insider Monkey

    10 Stocks Making Moves on Financial Results

    In this article, we will take a look at the 10 stocks making moves on financial results. You can skip our detailed analysis of these companies, and go directly to the 5 Stocks Making Moves on Financial Results. Investors are closely watching the third-quarter earnings season, with several big-cap companies releasing their financial results. Tesla, […]

  • Motley Fool

    3 Things Investors Should Love About Abbott's Q3 Results

    Abbott Laboratories (NYSE: ABT) has given investors plenty to like through the years. Abbott provided its third-quarter update before the market opened on Wednesday. Here are three things that investors should love about the healthcare-giant's Q3 results.

  • SmarterAnalyst

    Abbott Exceeds Q3 Expectations; Shares Jump 3.3%

    Abbott Laboratories (ABT), a multinational medical devices and health care company, reported better-than-expected third-quarter results driven by solid COVID-19 related sales, new product approvals, and overall strong demand for all of its offerings. Following the news, shares jumped 3.3% to close at $123.31 on October 20. The company reported adjusted earnings of $1.40 per share, up 42.9% year-over-year, beating consensus estimates of $0.93 per share. Additionally, quarterly sales stood at $10.